246 related articles for article (PubMed ID: 35359945)
1. Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response.
Wang K; Yang C; Li H; Liu X; Zheng M; Xuan Z; Mei Z; Wang H
Front Immunol; 2022; 13():859893. PubMed ID: 35359945
[TBL] [Abstract][Full Text] [Related]
2. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
[TBL] [Abstract][Full Text] [Related]
3. An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma.
Zhou J; Simon JM; Liao C; Zhang C; Hu L; Zurlo G; Liu X; Fan C; Hepperla A; Jia L; Tcheuyap VT; Zhong H; Elias R; Ye J; Henne WM; Kapur P; Nijhawan D; Brugarolas J; Zhang Q
Mol Cell; 2022 Aug; 82(16):3030-3044.e8. PubMed ID: 35764091
[TBL] [Abstract][Full Text] [Related]
4. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
5. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component.
Liu X; Si W; Liu X; He L; Ren J; Yang Z; Yang J; Li W; Liu S; Pei F; Yang X; Sun L
Mol Cancer; 2017 Nov; 16(1):175. PubMed ID: 29187213
[TBL] [Abstract][Full Text] [Related]
6. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.
Wang F; He L; Huangyang P; Liang J; Si W; Yan R; Han X; Liu S; Gui B; Li W; Miao D; Jing C; Liu Z; Pei F; Sun L; Shang Y
PLoS Biol; 2014 Mar; 12(3):e1001819. PubMed ID: 24667498
[TBL] [Abstract][Full Text] [Related]
7. Histone demethylase JMJD6 regulates cellular migration and proliferation in adipose-derived mesenchymal stem cells.
Shen C; Quan Q; Yang C; Wen Y; Li H
Stem Cell Res Ther; 2018 Aug; 9(1):212. PubMed ID: 30092848
[TBL] [Abstract][Full Text] [Related]
8. Jumonji domain-containing protein 6 protein and its role in cancer.
Yang J; Chen S; Yang Y; Ma X; Shao B; Yang S; Wei Y; Wei X
Cell Prolif; 2020 Feb; 53(2):e12747. PubMed ID: 31961032
[TBL] [Abstract][Full Text] [Related]
9. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4.
Wan J; Liu H; Yang L; Ma L; Liu J; Ming L
Int J Cancer; 2019 May; 144(10):2489-2500. PubMed ID: 30125344
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Jmjd6 cellular localization and testing for its involvement in histone demethylation.
Hahn P; Wegener I; Burrells A; Böse J; Wolf A; Erck C; Butler D; Schofield CJ; Böttger A; Lengeling A
PLoS One; 2010 Oct; 5(10):e13769. PubMed ID: 21060799
[TBL] [Abstract][Full Text] [Related]
11. Livin promotes colon cancer progression by regulation of H2A.X
Ge Y; Liu BL; Cui JP; Li SQ
Life Sci; 2019 Oct; 234():116788. PubMed ID: 31445935
[TBL] [Abstract][Full Text] [Related]
12. Compromised JMJD6 Histone Demethylase Activity Affects VHL Gene Repression in Preeclampsia.
Alahari S; Post M; Rolfo A; Weksberg R; Caniggia I
J Clin Endocrinol Metab; 2018 Apr; 103(4):1545-1557. PubMed ID: 29373688
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-106a-5p alleviated the resistance of cisplatin in lung cancer cells by targeting Jumonji domain containing 6.
Ge X; Jiang Y; Hu X; Yu X
Transpl Immunol; 2021 Dec; 69():101478. PubMed ID: 34607003
[TBL] [Abstract][Full Text] [Related]
14. Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma.
Zhang C; Lu X; Huang J; He H; Chen L; Liu Y; Wang H; Xu Y; Xing S; Ruan X; Yang X; Chen L; Xu D
Clin Transl Med; 2021 Feb; 11(2):e328. PubMed ID: 33634984
[TBL] [Abstract][Full Text] [Related]
15. A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivo.
Xiao RQ; Ran T; Huang QX; Hu GS; Fan DM; Yi J; Liu W
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2200753119. PubMed ID: 35969736
[TBL] [Abstract][Full Text] [Related]
16. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV
Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393
[TBL] [Abstract][Full Text] [Related]
17. Redistribution of demethylated RNA helicase A during foot-and-mouth disease virus infection: role of Jumonji C-domain containing protein 6 in RHA demethylation.
Lawrence P; Conderino JS; Rieder E
Virology; 2014 Mar; 452-453():1-11. PubMed ID: 24606677
[TBL] [Abstract][Full Text] [Related]
18. Jmjd6, a JmjC Dioxygenase with Many Interaction Partners and Pleiotropic Functions.
Kwok J; O'Shea M; Hume DA; Lengeling A
Front Genet; 2017; 8():32. PubMed ID: 28360925
[TBL] [Abstract][Full Text] [Related]
19. JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis.
Chen S; Wang M; Lu T; Liu Y; Hong W; He X; Cheng Y; Liu J; Wei Y; Wei X
Oncogene; 2023 Sep; 42(37):2737-2750. PubMed ID: 37567973
[TBL] [Abstract][Full Text] [Related]
20. JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma.
Wong M; Sun Y; Xi Z; Milazzo G; Poulos RC; Bartenhagen C; Bell JL; Mayoh C; Ho N; Tee AE; Chen X; Li Y; Ciaccio R; Liu PY; Jiang CC; Lan Q; Jayatilleke N; Cheung BB; Haber M; Norris MD; Zhang XD; Marshall GM; Wang JY; Hüttelmaier S; Fischer M; Wong JWH; Xu H; Perini G; Dong Q; George RE; Liu T
Nat Commun; 2019 Jul; 10(1):3319. PubMed ID: 31346162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
